2001 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF NITAZOXANIDE PLUS PEGINTERFERON AND RIBAVIRIN IN HCV GENOTYPE 1 NAIVE PATIENTS: WEEK 12 SUSTAINED VIROLOGIC RESPONSE RATE
2010 ◽
Vol 52
◽
pp. S463
◽
B.R. Bacon
◽
M.L. Shiffman
◽
J.K. Lim
◽
A. Berman
◽
V.K. Rustgi
◽
...